Yoshio Naomoto

Kawasaki Medical School — Japan

Medicine · Health Sciences

40h-index7.1kcitations349works3.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(50), Esophageal and GI Pathology(31), Gastric Cancer Management and Outcomes(30), Gastrointestinal Tumor Research and Treatment(26), Cancer Research and Treatments(26)

Publications347 total

Establishment and characterization of novel patient-derived esophageal tumoroids with long-term cultivability
Human Cell·2025· 1 cited
Correction: Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer
PLoS ONE·2024Open Access
Contrast-enhanced ultrasonography combined with superb microvascular imaging for preoperative diagnosis of sporadic intra-abdominal desmoid-type fibromatosis: A case report
Radiology Case Reports·2024· 2 citedOpen Access
Transforming tumoroids derived from ALK-positive pulmonary adenocarcinoma to squamous cell carcinoma in vivo
Human Cell·2024Open Access
Establishment and characterization of novel high mucus-producing lung tumoroids derived from a patient with pulmonary solid adenocarcinoma
Human Cell·2024· 4 citedOpen Access
A Study of the Risk Factors for 402 Patients with Esophageal Squamous Cell Carcinoma - A Retrospective Comparison with Health Checkup Participants
Internal Medicine·2024Open Access
Patient-derived tumoroid models of pulmonary large-cell neuroendocrine carcinoma: a promising tool for personalized medicine and developing novel therapeutic strategies
Cancer Letters·2024· 5 citedOpen Access
Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles
Molecular Cancer·2024· 18 citedOpen Access
Appendiceal mucocele pathologically classified as appendiceal epithelial hyperplasia and preoperatively diagnosed by contrast-enhanced ultrasonography: A case report
Radiology Case Reports·2024· 1 citedOpen Access
Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table 1 from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table S1 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table 1 from Dual Tyrosine Kinase Inhibitor for Focal Adhesion Kinase and Insulin-like Growth Factor-I Receptor Exhibits Anticancer Effect in Esophageal Adenocarcinoma <i>In vitro</i> and <i>In vivo</i>
2023Open Access
Supplementary Table S2 from Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
2023Open Access
Data from Tumorigenic Conversion of Primary Human Esophageal Epithelial Cells Using Oncogene Combinations in the Absence of Exogenous Ras
2023Open Access
page 1 of 18Next →

Frequent Co-authors

Tomoki Yamatsuji(25), Munenori Takaoka(20), Noriaki Tanaka(19), Minoru Haisa(19), Yasuhiro Shirakawa(14), Junji Matsuoka(13), Takuya Fukazawa(11), Tetsuji Nobuhisa(10), Motowo Nakajima(9), Yutaka Maeda(7), Hitoshi Nagatsuka(7), Mehmet Gündüz(7), T. Ohkawa(6), Kazuhiro Noma(6), Takayuki Motoki(6), Mehmet Gündüz(5), Hiroshi Nakagawa(5), Nobuyuki Tanaka(5), Nagio Takigawa(5), Tatsuo Okui(5)